| Gastric cancer: epidemiology, prevention, classification, and treatment |
179 |
| Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades |
46 |
| MALAT1: a potential biomarker in cancer |
43 |
| The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances |
37 |
| CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value |
35 |
| Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer |
29 |
| Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression |
29 |
| The clinical promise of immunotherapy in triple-negative breast cancer |
27 |
| Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study |
27 |
| MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells |
26 |
| Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis |
25 |
| High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database |
25 |
| Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression |
23 |
| Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets |
23 |
| The role of long non-coding RNA GAS5 in cancers |
22 |
| IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis |
22 |
| A review of soft-tissue sarcomas: translation of biological advances into treatment measures |
22 |
| Advances in antitumor effects of NSAIDs |
21 |
| miR-600 inhibits lung cancer via downregulating the expression of METTL3 |
20 |
| Circular RNA hsa_circ_0072309 inhibits proliferation and invasion of breast cancer cells via targeting miR-492 |
20 |
| Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kappa B signaling pathways |
20 |
| MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer |
19 |
| Human papillomavirus DNA in surgical smoke during cervical loop electrosurgical excision procedures and its impact on the surgeon |
19 |
| Upregulated circ RNA hsa_circ_0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma |
18 |
| Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer |
18 |
| Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies |
18 |
| Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3 |
18 |
| CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6KI via sponging miR-145-5p |
18 |
| Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer |
17 |
| Biliary tract cancers: current knowledge, clinical candidates and future challenges |
17 |
| An expression signature model to predict lung adenocarcinoma-specific survival |
17 |
| Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going |
17 |
| Bax, Bcl- and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy? |
17 |
| Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1 |
17 |
| Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors |
17 |
| Prognosis of patients with neuroendocrine tumor: a SEER database analysis |
16 |
| The prognostic value and mechanisms of lncRNA UCA1 in human cancer |
16 |
| A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer |
16 |
| The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
16 |
| Identification of chemoresistance-associated miRNAs in breast cancer |
16 |
| A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer |
16 |
| Overview of advances in vasculogenic mimicry - a potential target for tumor therapy |
15 |
| SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer |
15 |
| lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging |
15 |
| Long noncoding RNA SNHG6 functions as a competing endogenous RNA by sponging miR-181a-5p to regulate E2F5 expression in colorectal cancer |
15 |
| Radiation-induced skin reactions: mechanism and treatment |
15 |
| Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL suppressing colorectal cancer proliferation |
15 |
| The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
15 |
| miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-kappa B signaling via direct targeting of OTUB2 |
15 |
| Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/beta-catenin pathway in pancreatic cancer |
15 |
